Leigh Disease
|
0.640 |
GeneticVariation
|
disease |
BEFREE |
Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome.
|
14729820 |
2004 |
Leigh Disease
|
0.640 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we identified a novel Leigh syndrome causing NDUFS3 mutation and expanded the clinical spectrum caused by NDUFS3 mutations in this study.
|
30140060 |
2018 |
Leigh Disease
|
0.640 |
GeneticVariation
|
disease |
BEFREE |
Correction: A novel NDUFS3 mutation in a Chinese patient with severe Leigh syndrome.
|
30266949 |
2018 |
MITOCHONDRIAL COMPLEX I DEFICIENCY
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome.
|
14729820 |
2004 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome.
|
14729820 |
2004 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A Novel NDUFS3 mutation in a Chinese patient with severe Leigh syndrome.
|
30140060 |
2018 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
A Novel NDUFS3 mutation in a Chinese patient with severe Leigh syndrome.
|
30140060 |
2018 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing.
|
22499348 |
2012 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing.
|
22499348 |
2012 |
Venous Thromboembolism
|
0.110 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.
|
31420334 |
2019 |
Venous Thromboembolism
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
The meta-analyses did not confirm or exclude a beneficial or detrimental effect of low-dose VKA compared to no VKA on mortality (RR 0.99, 95% CI 0.64 to 1.55; RD 1 fewer per 1000, 95% CI 34 fewer to 52 more; low-certainty evidence), symptomatic catheter-related VTE (RR 0.61, 95% CI 0.23 to 1.64; RD 31 fewer per 1000, 95% CI 62 fewer to 51 more; low-certainty evidence), major bleeding (RR 7.14, 95% CI 0.88 to 57.78; RD 12 more per 1000, 95% CI 0 fewer to 110 more; low-certainty evidence), minor bleeding (RR 0.69, 95% CI 0.38 to 1.26; RD 15 fewer per 1000, 95% CI 30 fewer to 13 more; low-certainty evidence), premature catheter removal (RR 0.82, 95% CI 0.30 to 2.24; RD 29 fewer per 1000, 95% CI 114 fewer to 202 more; low-certainty evidence), and catheter-related infection (RR 1.17, 95% CI 0.74 to 1.85; RD 71 more per 1000, 95% CI 109 fewer to 356; low-certainty evidence).LMWH versus VKAThree RCTs (641 participants) compared LMWH to VKA in adults.
|
29856471 |
2018 |
Hypertensive disease
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.
|
27618448 |
2016 |
Venous Thrombosis
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Caution in interpreting results from imputation analysis when linkage disequilibrium extends over a large distance: a case study on venous thrombosis.
|
22675575 |
2012 |
Fasting blood glucose measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.
|
22885924 |
2012 |
Fasting blood sugar result
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.
|
22885924 |
2012 |
Rheumatoid Arthritis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A priori, UA patients had a 35% (95% CI 30-40%) risk of developing RA, which increased to 66% (95% CI 57-75%) in patients who were ACPA-positive.
|
17341507 |
2007 |
Presenile dementia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Median age at onset was 35 years (95% CI 30-36) for asymptomatic pre-MCI, 38 years (37-40) for symptomatic pre-MCI, 44 years (43-45) for MCI, and 49 years (49-50) for dementia.
|
21296022 |
2011 |
Graft-vs-Host Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The incidences of grades II-IV acute graft-versus-host disease (GVHD) and chronic GVHD were 34 (95% CI 30-37%) and 51 (95% CI 46-56%), respectively.
|
29713245 |
2018 |
Septicemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Pooled in-hospital mortality for Sepsis-2-defined sepsis and severe sepsis was 19% (95% CI 12-29%) and 39% (95% CI 30-47%) respectively, and sepsis mortality was associated with the proportion of HIV-infected participants.
|
31186062 |
2019 |
Tuberculosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Nine studies on tuberculosis (TB) were pooled to give an overall incidence rate estimate of 60 (95% confidence interval [CI] 30-70) per 1,000 child-years.
|
30945963 |
2019 |
Sepsis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Pooled in-hospital mortality for Sepsis-2-defined sepsis and severe sepsis was 19% (95% CI 12-29%) and 39% (95% CI 30-47%) respectively, and sepsis mortality was associated with the proportion of HIV-infected participants.
|
31186062 |
2019 |
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A biochemical diagnosis of complex I deficiency on cultured amniocytes from a later pregnancy was confirmed through the identification of disease causing NDUFS3 mutations in these cells.
|
14729820 |
2004 |
Dementia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Median age at onset was 35 years (95% CI 30-36) for asymptomatic pre-MCI, 38 years (37-40) for symptomatic pre-MCI, 44 years (43-45) for MCI, and 49 years (49-50) for dementia.
|
21296022 |
2011 |
Acute GVH disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The incidences of grades II-IV acute graft-versus-host disease (GVHD) and chronic GVHD were 34 (95% CI 30-37%) and 51 (95% CI 46-56%), respectively.
|
29713245 |
2018 |